KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $4,000 | -73.3% | 400 | -71.4% | 0.00% | -100.0% |
Q1 2021 | $15,000 | -31.8% | 1,400 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $22,000 | +10.0% | 1,400 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $20,000 | -47.4% | 1,400 | -30.0% | 0.00% | -50.0% |
Q2 2020 | $38,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $38,000 | +22.6% | 2,000 | +25.0% | 0.00% | +100.0% |
Q4 2019 | $31,000 | +93.8% | 1,600 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $16,000 | +60.0% | 1,600 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $10,000 | +42.9% | 1,600 | +45.5% | 0.00% | 0.0% |
Q1 2019 | $7,000 | +16.7% | 1,100 | +83.3% | 0.00% | 0.0% |
Q4 2018 | $6,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |